Clinical Trial

Repurposing Lithium for Parkinson's Disease: a RCT

Active, Not Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
This study will examine the effects of lithium 20mg/day compared to placebo on MRI and blood-based biomarkers among 20 early-stage Parkinson's disease patients.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-03-24; most recent amendment 2026-06-12.
Status change: Recruiting → Active, Not Recruiting 2025-07-04
Status change: Not Yet Recruiting → Recruiting 2024-10-24
Trial Details
NCT Number NCT06339034
Lead Sponsor State University of New York at Buffalo
Collaborators: Cure Parkinson's
Conditions Parkinson Disease
Enrollment 20 participants
Start Date 2024-07-03
Primary Completion 2026-08 (estimated)
Study Completion 2026-09 (estimated)
Updated on ClinicalTrials.gov 2026-06-16